DLK Investment Management LLC Has $4.92 Million Stake in Danaher Corporation $DHR

DLK Investment Management LLC lifted its stake in Danaher Corporation (NYSE:DHR) by 3.7% in the second quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 24,904 shares of the conglomerate’s stock after purchasing an additional 883 shares during the quarter. Danaher accounts for 1.9% of DLK Investment Management LLC’s portfolio, making the stock its 25th largest position. DLK Investment Management LLC’s holdings in Danaher were worth $4,920,000 as of its most recent SEC filing.

A number of other institutional investors and hedge funds have also recently added to or reduced their stakes in the stock. Pines Wealth Management LLC acquired a new position in Danaher in the 2nd quarter valued at approximately $230,000. Sunpointe LLC purchased a new position in shares of Danaher during the 2nd quarter valued at $288,000. Westshore Wealth LLC purchased a new stake in shares of Danaher during the second quarter worth $201,000. Pallas Capital Advisors LLC boosted its position in Danaher by 6.5% during the second quarter. Pallas Capital Advisors LLC now owns 29,018 shares of the conglomerate’s stock valued at $5,732,000 after purchasing an additional 1,775 shares during the last quarter. Finally, Werlinich Asset Management LLC purchased a new position in Danaher in the second quarter valued at about $210,000. 79.05% of the stock is owned by hedge funds and other institutional investors.

Danaher Stock Performance

DHR opened at $190.43 on Wednesday. The stock’s 50 day simple moving average is $200.77 and its 200-day simple moving average is $198.59. The company has a current ratio of 1.62, a quick ratio of 1.22 and a debt-to-equity ratio of 0.32. The stock has a market cap of $136.36 billion, a PE ratio of 40.52, a P/E/G ratio of 2.63 and a beta of 0.75. Danaher Corporation has a 1 year low of $171.00 and a 1 year high of $279.90.

Danaher (NYSE:DHR) last posted its quarterly earnings results on Tuesday, July 22nd. The conglomerate reported $1.80 earnings per share for the quarter, topping analysts’ consensus estimates of $1.64 by $0.16. Danaher had a net margin of 14.21% and a return on equity of 10.70%. The firm had revenue of $5.94 billion for the quarter, compared to the consensus estimate of $5.83 billion. During the same quarter in the previous year, the company earned $1.72 earnings per share. The business’s revenue was up 3.4% compared to the same quarter last year. Danaher has set its FY 2025 guidance at 7.700-7.800 EPS. Sell-side analysts forecast that Danaher Corporation will post 7.63 EPS for the current year.

Danaher Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Friday, October 31st. Shareholders of record on Friday, September 26th will be paid a dividend of $0.32 per share. The ex-dividend date is Friday, September 26th. This represents a $1.28 dividend on an annualized basis and a yield of 0.7%. Danaher’s dividend payout ratio (DPR) is currently 27.23%.

Analyst Ratings Changes

Several equities research analysts recently commented on DHR shares. Wall Street Zen raised Danaher from a “hold” rating to a “buy” rating in a research note on Friday, June 27th. Scotiabank upgraded shares of Danaher from a “sector perform” rating to a “sector outperform” rating and set a $275.00 price target on the stock in a research note on Friday, July 11th. UBS Group cut their price target on shares of Danaher from $240.00 to $225.00 and set a “buy” rating on the stock in a report on Wednesday, July 23rd. Guggenheim reiterated a “buy” rating and issued a $250.00 price objective on shares of Danaher in a report on Wednesday, July 23rd. Finally, Royal Bank Of Canada set a $241.00 target price on Danaher in a report on Tuesday, September 2nd. Seventeen investment analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the stock. Based on data from MarketBeat.com, the company has an average rating of “Moderate Buy” and an average target price of $246.35.

Insiders Place Their Bets

In other news, Director Teri List sold 2,778 shares of the company’s stock in a transaction that occurred on Friday, August 22nd. The stock was sold at an average price of $211.06, for a total value of $586,324.68. Following the sale, the director directly owned 20,751 shares in the company, valued at approximately $4,379,706.06. This represents a 11.81% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is accessible through this link. Insiders own 11.20% of the company’s stock.

About Danaher

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.